Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891626807> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2891626807 abstract "4040 Background: Recently, anti-programmed death 1 (PD-1) or its ligand (PD-L1) antibodies have shown promising activities in metastatic gastric cancer (MGC). However, little is known about detailed clinicopathological features of PD-L1 expression in patients (pts) with MGC. Methods: Pts with histologically confirmed MGC were eligible for this prospective observational study. PD-L1 expression on tumor cell (TC) or inflammatory cell (IC) and mismatch repair (MMR) were analyzed by immunohistochemistry (IHC). Epstein–Barr virus (EBV) was detected by in situ hybridization. The expressions of tyrosine kinase receptors (RTKs) such as HER2, EGFR and MET and cancer genome alterations were also evaluated by IHC or next generation sequencing. Results: A total of 237 pts were enrolled from September 2015 to December 2016. Samples of 199 (84.0%) pts were obtained from biopsy. PD-L1 expression on TC and IC was positive in 27 (11.4%) and 167 pts (70.5%), respectively. One hundred and seventy-one pts (72.2%) had positive PD-L1 expression on either TC or IC. MMR deficient (D-MMR) and EBV was detected in 14 (6.9%, n = 203) and 14 pts (5.9%, n = 237), respectively. PD-L1 expression on TC was more frequently observed in pts with D-MMR (P < 0.001) and KRAS mutation (P < 0.001), while that on IC was more frequently observed in pts with EBV+ (P = 0.045), lymph node metastasis (P = 0.001), and lung metastasis (P = 0.045). In contrast, pts with peritoneal metastasis were associated with less frequent PD-L1 expression in IC (P = 0.003). A significant association was not observed between PD-L1 expression and RTKs expression or presence of other gene alterations. D-MMR was significantly associated with intestinal type (P = 0.026) and absence of liver metastasis (P = 0.022). PD-L1 expression on either TC or IC was not prognostic factor (hazard ratio; 0.92, P = 0.741). Seven pts with D-MMR and seven pts with EBV+ MGC were enrolled in clinical trials of anti-PD-1/PD-L1 antibodies. Conclusions: PD-L1 expression in MGC was associated with some clinicopathological features. Impact of these characteristics on efficacy of anti-PD-1/PD-L1 antibody warrants further evaluation." @default.
- W2891626807 created "2018-09-27" @default.
- W2891626807 creator A5001115937 @default.
- W2891626807 creator A5015799240 @default.
- W2891626807 creator A5019984630 @default.
- W2891626807 creator A5024904484 @default.
- W2891626807 creator A5033862426 @default.
- W2891626807 creator A5038375140 @default.
- W2891626807 creator A5043738572 @default.
- W2891626807 creator A5046439279 @default.
- W2891626807 creator A5060366426 @default.
- W2891626807 creator A5062748030 @default.
- W2891626807 creator A5063648563 @default.
- W2891626807 creator A5082685387 @default.
- W2891626807 date "2017-05-20" @default.
- W2891626807 modified "2023-09-22" @default.
- W2891626807 title "Clinicopathological features of program death ligand-1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer." @default.
- W2891626807 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.4040" @default.
- W2891626807 hasPublicationYear "2017" @default.
- W2891626807 type Work @default.
- W2891626807 sameAs 2891626807 @default.
- W2891626807 citedByCount "1" @default.
- W2891626807 countsByYear W28916268072018 @default.
- W2891626807 crossrefType "journal-article" @default.
- W2891626807 hasAuthorship W2891626807A5001115937 @default.
- W2891626807 hasAuthorship W2891626807A5015799240 @default.
- W2891626807 hasAuthorship W2891626807A5019984630 @default.
- W2891626807 hasAuthorship W2891626807A5024904484 @default.
- W2891626807 hasAuthorship W2891626807A5033862426 @default.
- W2891626807 hasAuthorship W2891626807A5038375140 @default.
- W2891626807 hasAuthorship W2891626807A5043738572 @default.
- W2891626807 hasAuthorship W2891626807A5046439279 @default.
- W2891626807 hasAuthorship W2891626807A5060366426 @default.
- W2891626807 hasAuthorship W2891626807A5062748030 @default.
- W2891626807 hasAuthorship W2891626807A5063648563 @default.
- W2891626807 hasAuthorship W2891626807A5082685387 @default.
- W2891626807 hasConcept C104317684 @default.
- W2891626807 hasConcept C121608353 @default.
- W2891626807 hasConcept C126322002 @default.
- W2891626807 hasConcept C141231307 @default.
- W2891626807 hasConcept C143998085 @default.
- W2891626807 hasConcept C159047783 @default.
- W2891626807 hasConcept C2522874641 @default.
- W2891626807 hasConcept C2781375147 @default.
- W2891626807 hasConcept C502942594 @default.
- W2891626807 hasConcept C54355233 @default.
- W2891626807 hasConcept C71924100 @default.
- W2891626807 hasConcept C86803240 @default.
- W2891626807 hasConceptScore W2891626807C104317684 @default.
- W2891626807 hasConceptScore W2891626807C121608353 @default.
- W2891626807 hasConceptScore W2891626807C126322002 @default.
- W2891626807 hasConceptScore W2891626807C141231307 @default.
- W2891626807 hasConceptScore W2891626807C143998085 @default.
- W2891626807 hasConceptScore W2891626807C159047783 @default.
- W2891626807 hasConceptScore W2891626807C2522874641 @default.
- W2891626807 hasConceptScore W2891626807C2781375147 @default.
- W2891626807 hasConceptScore W2891626807C502942594 @default.
- W2891626807 hasConceptScore W2891626807C54355233 @default.
- W2891626807 hasConceptScore W2891626807C71924100 @default.
- W2891626807 hasConceptScore W2891626807C86803240 @default.
- W2891626807 hasLocation W28916268071 @default.
- W2891626807 hasOpenAccess W2891626807 @default.
- W2891626807 hasPrimaryLocation W28916268071 @default.
- W2891626807 hasRelatedWork W2092449939 @default.
- W2891626807 hasRelatedWork W2315767088 @default.
- W2891626807 hasRelatedWork W2462620900 @default.
- W2891626807 hasRelatedWork W2550990550 @default.
- W2891626807 hasRelatedWork W2617410843 @default.
- W2891626807 hasRelatedWork W2799891476 @default.
- W2891626807 hasRelatedWork W2805429041 @default.
- W2891626807 hasRelatedWork W2890805632 @default.
- W2891626807 hasRelatedWork W2891184841 @default.
- W2891626807 hasRelatedWork W2891537822 @default.
- W2891626807 hasRelatedWork W2891577923 @default.
- W2891626807 hasRelatedWork W2898278776 @default.
- W2891626807 hasRelatedWork W2994918489 @default.
- W2891626807 hasRelatedWork W2995948556 @default.
- W2891626807 hasRelatedWork W3088690425 @default.
- W2891626807 hasRelatedWork W3107633401 @default.
- W2891626807 hasRelatedWork W3117348393 @default.
- W2891626807 hasRelatedWork W3131517021 @default.
- W2891626807 hasRelatedWork W3171414289 @default.
- W2891626807 hasRelatedWork W3183064152 @default.
- W2891626807 isParatext "false" @default.
- W2891626807 isRetracted "false" @default.
- W2891626807 magId "2891626807" @default.
- W2891626807 workType "article" @default.